News and Trends 10 Sep 2025
Kriya Therapeutics has raised over $1.2 billion, but for what?
Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space.
- Latest Posts
In Depth 10 Sep 2025
When rare diseases are not so rare after all: A closer look at where and why this happens
Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin marriages.
News and Trends 9 Sep 2025
Top biotech deals in August 2025
Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules.
Advanced expression vector design to overcome challenges in developing multichain biotherapeutics
Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems.
News and Trends 8 Sep 2025
With Lykos CRL now public, FDA opens new era of accountability
As the release of a CRL declining Lykos’ therapy generates a strong reaction from MAPS, delve into what this new transparency could change.
In Depth 5 Sep 2025
Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer?
Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks.
ADVERTISEMENT
ADVERTISEMENT
Podcast 5 Sep 2025
Navigating the biotech development journey from first steps to global scale with Lonza
Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies.
Interview 3 Sep 2025
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field.
In Depth 3 Sep 2025
How are biotechs tackling malaria?
As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria.
In Depth 2 Sep 2025
The biggest biotech funding rounds in August 2025
Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025.
In Depth 1 Sep 2025
Blood Cancer Awareness Month: What biotech holds in store
As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines.
Webinars 1 Sep 2025
Organoids in cancer research: Paving the way for faster drug development across cancer indications
Discover how patient-derived organoids enable smarter, quicker oncology drug development.
ADVERTISEMENT
